Slide deck
by
Oviedo-Joekes, Eugenia
Release Date
2018
Geography
Canada
Language of Resource
English
Full Text Available
Yes
Open Access / OK to Reproduce
No
Peer Reviewed
No
Objective
The aim of this presentation is to examine the safety profile of injectable
hydromorphone and diacetylmorphine by analyzing rates of adverse
events (AEs) in the SALOME study and exploring if they were
associated with dose and patterns of treatment attendance.
Findings/Key points
When injectable hydromorphone and diacetylmorphine are individually dosed and monitored, their opioid-related side effects, including potential fatal overdoses, are safely mitigated and treated by health care providers. Related adverse events did not lead to more missed treatment days and the dose prescribed does not seem to play a direct or sole role.
Keywords
Safer supply
Evidence base
Overdose
Outcomes
